Tag:

Nuron

Latest Headlines

Latest Headlines

Nuron Biotech nabs $80M from HealthCare Royalty Partners

December 20, 2012 | By
Just days after snagging Pfizer's ($PFE) meningitis, sepsis and pneumonia vaccine, Nuron Biotech landed an $80 million deal to further elevate its expanding porfolio of vaccines.

Nuron Biotech bags $80M deal to back vaccines portfolio, PhIII MS drug work

FierceBiotech | December 20, 2012
The investment cash has been flowing into biotechnology this week. This morning Nuron Biotech joined the parade, announcing an $80 million deal designed to boost its work expanding a portfolio of vaccines while pushing ahead on a late-stage development program for multiple sclerosis.

Nuron acquires Pfizer's meningitis vaccine

December 11, 2012 | By
Startup Nuron Biotech acquired from Pfizer a vaccine to protect against meningitis, sepsis and pneumonia for an undisclosed amount.

Nuron buys Hib vaccine from Wyeth, plots relaunch

April 7, 2011 | By
Exton, PA-based Nuron is paying an undisclosed sum to purchase Hib vaccine HibTITER from Pfizer's Wyeth unit. The vaccine was previously approved, but Wyeth stopped selling it several years ago after
Related Tags

Nuron Press Releases

  • Nuron Biotech Expands Portfolio With License of Therapeutic and Prophylactic Hepatitis Vaccine Candidates
  • Nuron Biotech to Develop Long-acting Version of Proprietary Recombinant Human Interferon Beta-1b Utilizing PolyTherics' TheraPEG
Press Releases
  • FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4
  • American Gene Technologies Welcomes Visionary Leader to Board of Directors
  • Antares Pharma Announces CEO Transition
  • Gary Zieziula Appointed President And Managing Director Of EMD Serono
  • Aprecia Pharmaceuticals Set to Advance 3D Printed Drug Pipeline with Completion of $35 Million Financing Led by Deerfield Management
  • More Press Releases
Sponsored Links